Integrated bioinformatics and wet-lab analysis revealed prominent inflammatory genes of Extracellular Matrix as prognostic biomarkers in patients with advance IBD requiring early surgery
Abstract
BackgroundThe number of patients with inflammatory bowel disease (IBD) is increasing worldwide. Due to the fact that at the age of 20 to 30 years, this autoimmune disease is very common; Investigating and identifying prognostic biomarkers in advanced IBD is very important; Because according to the identification of these biomarkers, patients who need early surgery can be nominated and undergo surgery without wasting time and treatment costs. In this study, with the aim of identifying effective biomarkers involved in the inflammatory part of extracellular matrix (ECM) in the early surgery of IBD, separately from Crohns disease and ulcerative colitis. MethodIn this study, we examined 50 patients in both patient groups as well as the normal group. The expression of the nominated genes MASP2, DKC1, HNF4A, and STAT3 was analyzed using quantitative polymerase chain reaction (Q-PCR) and relative quantification was determined using the 2-{Delta}{Delta}Ct method. ROC curve analysis was performed to compare IBD (UC & CD) and normal for the investigated genes. The correlation between adhesion molecule gene expression and immunophenotype was analyzed. Also we comprehensively analyzed the genetic alteration, prognostic value and gene regulatory networks using multiple databases. ResultThe obtained results showed that MASP2 and DKC1 genes were significantly expressed in advanced UC patients, as well as HNF4A and STAT3 in advanced CD patients. ConclusionIt can be stated that the biomarker panel MASP2, DKC1, HNF4A, and STAT3 related to them have a significant prognostic role in the candidates of IBD patients for early surgery. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=109 SRC="FIGDIR/small/570869v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@1f1de07org.highwire.dtl.DTLVardef@27db16org.highwire.dtl.DTLVardef@a095f2org.highwire.dtl.DTLVardef@d46c38_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A blood-based prognostic biomarker in inflammatory bowel disease
Daniele Biasci, J.C. Lee, … Kenneth G. C. Smith·bioRxiv·Jan 30, 2019
- Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
R. Kalla, A. T. Adams, … J. Satsangi·bioRxiv·Aug 31, 2020
- Keratin 7 protein presence in stool is indicative of active pediatric-onset inflammatory bowel disease
Maria A. Ilomäki, Ekta Kotharkar, … Diana M. Toivola·bioRxiv·Apr 22, 2026
- A metaproteomics-based meta study of samples from patients with inflammatory bowel disease identifies potential markers for diagnosis and therapy monitoring
Maximilian Wolf, Luca Knipper, … Robert Heyer·bioRxiv·Nov 6, 2025
- Macrophage-specific NF-kappa B activation dynamics can segregate inflammatory bowel disease patients
S. Papoutsopoulou, M. D. Burkitt, … C. Probert·bioRxiv·Jan 30, 2019
- TCF21 loss identifies a conserved inflammation-associated fibroblast state across Crohn's disease and ulcerative colitis
Mor Hindi Malowany, N M Franklin, … Richard Lee Gieseck·bioRxiv·Oct 26, 2026